Zurueck zur Suche

Reporte zur Charge U024508

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 7 FL 2 TX 2 ME 1 IL 1 KS 1

VAERS 2523837

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U024508

mild
Staat
FL
Alter
1,6
Geschlecht
F
Eingang
05.12.2022
Impfdatum
18.11.2022
Beginn
30.11.2022
Tage bis Beginn
12,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

pt tolerated well at the visit, when I was notified on 11.29.22. I notified mom on 11/30/22 and she mentioned a rash that she stated started on 11/28/22 and that noticed she seen stated that she would look her over. 20 mins later she called back out rate because she now had to notify dad who is against vaccination. We scheduled them to come in baby was looked over by the doctor and they decided not to vax anymore.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2578489

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
ME
Alter
-
Geschlecht
U
Eingang
09.02.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Product confusion Product selection error Wrong product administered

Symptomtext

she then inadvertently administered the PROQUAD to the patient instead of the MMR II; she confused the PROQUAD for the MMR II as they were stored in the same exact spot; 23-DEC-1985, PROQUAD was inadvertently administered to a patient; confused the PROQUAD for the MMR II as they were stored in the same exact spot; No additional AE reported; This spontaneous report was received from a health care professional and referred to a currently 37-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included sterile diluent (manufacturer unknown). On an unknown date, measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (anatomical location, strength, dose, route, lot number, and expiration date were not reported; for prophylaxis) was scheduled to be administered, but the reporter confused the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) for the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) as they were stored in the same exact spot (Product confusion, Product selection error). The caller said she then inadvertently administered the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (albumin status recombinant Human albumin (rHA), 0.5 milliliter, lot #U024508, expiration date: 02-FEB-2023, administered for prophylaxis; strength, and route of administration were not provided) to the patient instead of the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (Wrong product administered, Product administered to patient of inappropriate age). There was no adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2522917

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
IL
Alter
16,0
Geschlecht
M
Eingang
05.12.2022
Impfdatum
23.11.2022
Beginn
23.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age Vaccination error

Symptomtext

patient is greater than 12 years old, and received ProQuad which should be used on children less than 12 years of age. Patient did not have any adverse reaction to this vaccine error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
exposure to disaster, war and other hostilities
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2461927

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
TX
Alter
1,0
Geschlecht
F
Eingang
27.09.2022
Impfdatum
27.09.2022
Beginn
27.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

PT CAME IN FOR 12MTH CHECKUP , GOT IMMUNIZATION READY TO BE ADMINISTERED . ADMINSTERED THE IMMUNIZATION TO PATIENT AND WAS READY TO INPUT IMMUNIZATION IN SYSTEM I NOTICED THAT I HAD ADMINSTERED THE WRONG IMMUNIZATION. I LET MY PROVIDER KNOW OF THE MISTAKE AND CALLED HEALTH DEPARTMENT. TO BE SURE, ALSO CALLED THE CDC TO JUST BE SURE THAT ADMINERSTERING THE WRONG IMMUNIATION WON'T HAVE AN EFFECT ON THE CHILD. CALLED THE PT MOTHER AND LET HER KNOW OF THE SITUATION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
DIARRHEA
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2335483

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
27.06.2022
Impfdatum
25.05.2022
Beginn
25.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; A patient was administered PROQUAD after a temperature excursion.; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 25-MAY-2022, the patient was vaccinated an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot number U024508 with expiration date: 02-FEB-2023, as prophylaxis (dose, vaccination scheme frequency, anatomical location, and route of administration were not reported). The vaccine suffered a temperature excursion at 8.3 fahrenheit (F) degrees for 15 minutes (product storage error). There were no previous temperature excursions. No adverse event was reported. ; Sender's Comments: US-009507513-2206USA000886: US-009507513-2206USA000990:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2334804

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
25.06.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE reported; Medical assistant reporting that a patient was administered PROQUAD after a temperature excursion. No additional information provided. Additional AE cases: 02177149, 02177160, 02177161, 02177162, 02177163, 02177164, 02177166, 02177167, 02177168. No a; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. Information regarding their medical history, concurrent conditions and concomitant therapies was not reported. On 31-MAY-2022, the patient was vaccinated with an improperly stored measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) subcutaneous injection, lot # U024508, expiration date 02-FEB-2023 (dose and route of administration were not reported) for prophylaxis (product storage error). The administered vaccine was stored in 8.3 degrees Fahrenheit (F) for 15 minutes. No previous temperature excursion was reported. The reporter confirmed the patient had no adverse experience. The reporter stated that the company informed her she could use the product. As of 07-JUN-2022, no further information was available for this case. This is one of several reports from the same reporter.; Sender's Comments: US-009507513-2206USA000990: US-009507513-2206USA000833: US-009507513-2206USA001100: US-009507513-2206USA001101: US-009507513-2206USA001052: US-009507513-2206USA000982: US-009507513-2206USA000988: US-009507513-2206USA001078: US-009507513-2206USA001045:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2316238

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
11.06.2022
Impfdatum
01.06.2022
Beginn
01.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Medical assistant reporting that a patient was administered PROQUAD after a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided. On 01-JUN-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin [rHA]) (PROQUAD) subcutaneous injection, lot # U024508, expiration date 02-FEB-2023 (dose, route of administration, anatomical location were not reported) for prophylaxis (Product storage error). Administered dose of the vaccine was stored in temperature of 8.3 degrees Fahrenheit for 15 minutes. There were no previous temperature excursions reported. There was no additional adverse event reported (no adverse event). No further information was available.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2312429

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
08.06.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Medical assistant reporting that a patient was administered PROQUAD after a temperature excursion. No additional information provided. Additional AE cases: 02177149, 02177160, 02177161, 02177162, 02177163, 02177164, 02177165, 02177166, 02177167. No a; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 31-MAY-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, lot #U024508, expiration date: 02-FEB-2023, administered subcutaneously for prophylaxis (strength and exact dose were not provided). The measles, mumps, rubella and varicella (Oka Merck) virus vaccine live (PROQUAD) was administered after a temperature excursion (8.3F) in a time frame of 15 Minutes. No additional adverse event (AE) and no PQC were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2311172

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
07.06.2022
Impfdatum
01.06.2022
Beginn
01.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; a patient was administered PROQUAD after a temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not reported. On 01-JUN-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection (lot #U024508 with an expiration date on 02-FEB-2023) administered for prophylaxis (strength, dose and route of administration were not provided) after a temperature excursion of 8.3F Fahrenheit (?F) during a time frame of 0 hours, 15 minutes and 0 seconds. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2311171

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
07.06.2022
Impfdatum
01.06.2022
Beginn
01.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; a patient was administered PROQUAD after a temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not reported. On 01-JUN-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection (lot #U024508 with an expiration date on 02-FEB-2023) administered for prophylaxis (strength, dose and route of administration were not provided) after a temperature excursion of 8.3F Fahrenheit (?F) during a time frame of 0 hours, 15 minutes and 0 seconds. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2309385

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
04.06.2022
Impfdatum
26.05.2022
Beginn
26.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No adverse event; Incorrect product storage; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 26-MAY-2022, the patient was vaccinated an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # U024508 with expiration date: 02-FEB-2023, as prophylaxis (dose and route of administration were not reported). The vaccine suffered a temperature excursion at 8.3 F degrees for 15 minutes. There were no previous temperature excursions. No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2245464

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
21.04.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE or PQC reported; Caller explained the PROQUAD was administered after a temperature excursion; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. The pertinent medical history, concomitant therapies and drug allergy or reactions were not provided. On 05-APR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, (lot #U024508, expiration date: 02-FEB-2023, therapy type: rHA) for prophylaxis (strength, route of administration were not provided) for prophylaxis after a temperature excursion: 12.95 F for 21 hours 15 minutes 0 seconds (product storage error). There was no previous temperature excursion. There was no additional adverse event (AE) or product quality compliant (PQC) reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2225457

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
FL
Alter
4,0
Geschlecht
F
Eingang
10.04.2022
Impfdatum
06.04.2022
Beginn
07.04.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Erythema Oedema Skin warm Tenderness

Symptomtext

Localized 6.5cm x 7.5cm area of cellulitis (erythema, edema, warmth, and tenderness to palpation) diagnosed 3 days after the immunization. Treated with PO clindamycin.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cellulitis
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None reported by parent
Vorgeschichte
None reported by parent
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2089709

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024508

gering
Staat
KS
Alter
2,0
Geschlecht
F
Eingang
05.02.2022
Impfdatum
23.12.2021
Beginn
23.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No adverse event; PROQUAD was improperly stored on 15-DEC-2021 and administered to a patient; This non-valid spontaneous report was received from a nurse and referred to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided. On an unknown date the patient was vaccinated with measles, mumps, rubella, and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD), (unspecified dose, frequency, route of administration, lot # T032149 has been verified to be a valid lot number, expiration date was reported and established as 20-MAR-2022, lot # U024508 has been verified to be a valid lot number, expiration date was reported and established as 02-FEB-2023, lot # U009261 has been verified to be a valid lot number, expiration date was reported and established as 19-SEP-2022, lot # U026794, expiration date: 26-FEB-2023, vaccination site was not provided) for prophylaxis. It was reported that one dose of measles, mumps, rubella, and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD), was improperly stored on 15-DEC-2021 and was administered to a patient. on an unknown date (product storage error). The vaccine was stored at a temperature of -8.1 Celsius (C) for a time frame of 8 hours and 35 minutes with no previous temperature excursion. No product quality complaint (PQC) and no additional adverse event (AEs) was reported. This case was considered non-valid due the lack of patient identifiers. Follow-up information was received from the nurse on 01-FEB-2022. Demographics of the patient were provided. The case concerned a female patient of 2 years and 4 months old. Concomitant vaccines administered were diphtheria vaccine toxoid, hib vaccine conj (TET TOX), pertussis vaccine acellular 5-component, polio vaccine inact 3v (MRC 5), tetanus vaccine toxoid (PENTACEL) and influenza vaccine (FLUZONE.) On 23-DEC-2021, the patient was vaccinated with first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) subcutaneous route lot number U024508 (rHA) expiration date 02-FEB-2023 as prophylaxis. The nurse reported that the freezer was found out to be out of range due to a digital data logger. The problem was corrected, however, the vaccine was administered before the problem was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-